PHASE-I TRIAL OF THE COMBINATION OF 6-METHYLMERCAPTOPURINE RIBOSIDE AND 5-FLUOROURACIL

被引：0
|
作者：
WIEMANN, MC
CRABTREE, GW
WEITBERG, AB
SPREMULLI, EN
CUMMINGS, FJ
MURRAY, C
CALABRESI, P
机构：
来源：
MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY | 1988年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：113 / 116
页数：4
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF PALA AND 6-METHYLMERCAPTOPURINE RIBOSIDE (MMPR) IN COMBINATION WITH 5-FLUOROURACIL IN ADVANCED PANCREATIC-CANCER
    REDEI, I
    GREEN, F
    HOFFMAN, JP
    WEINER, LM
    SCHER, R
    ODWYER, PJ
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 319 - 321
  • [2] PHASE-I TRIAL OF FLUOROURACIL MODULATION BY N-PHOSPHONACETYL-L-ASPARTATE AND 6-METHYLMERCAPTOPURINE RIBOSIDE - OPTIMIZATION OF 6-METHYLMERCAPTOPURINE RIBOSIDE DOSE AND SCHEDULE THROUGH BIOCHEMICAL-ANALYSIS OF SEQUENTIAL TUMOR-BIOPSY SPECIMENS
    ODWYER, PJ
    HUDES, GR
    COLOFIORE, J
    WALCZAK, J
    HOFFMAN, J
    LACRETA, FP
    COMIS, RL
    MARTIN, DS
    OZOLS, RF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (17) : 1235 - 1240
  • [3] PHASE-I TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, AND CISPLATIN IN COMBINATION
    ODWYER, PJ
    CORNFELD, MJ
    PETER, R
    COMIS, RL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (02) : 131 - 134
  • [4] PHASE-I CLINICAL AND PHARMACOLOGIC TRIAL OF TRIMETREXATE IN COMBINATION WITH 5-FLUOROURACIL
    HUDES, GR
    LACRETA, F
    DELAP, RJ
    GRILLOLOPEZ, AJ
    CATALANO, R
    COMIS, RL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (02) : 117 - 122
  • [5] Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside
    Hageboutros, A
    Hudes, GR
    Brennan, J
    Green, F
    Hoffman, J
    LaCreta, FP
    Colofiore, J
    Martin, DS
    Ozols, RF
    ODwyer, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (03) : 229 - 234
  • [6] Synthesis and crystal structure of a silver(I) 6-methylmercaptopurine riboside complex
    Al-Mahamad, Lamia L. G.
    Clegg, William
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2024, 80 (Pt 3): : 80 - +
  • [7] COMPARISON OF PHARMACOKINETICS OF 5-FLUOROURACIL AND 5-FLUOROURACIL WITH CONCURRENT THYMIDINE INFUSIONS IN A PHASE-I TRIAL
    KIRKWOOD, JM
    ENSMINGER, W
    ROSOWSKY, A
    PAPATHANASOPOULOS, N
    FREI, E
    CANCER RESEARCH, 1980, 40 (01) : 107 - 113
  • [8] PHASE-I TRIAL OF INTRAPERITONEAL 5-FLUOROURACIL AND FOLINIC ACID
    BUDD, GT
    SCHREIBER, MJ
    STEIGER, E
    BUKOWSKI, RM
    WEICK, JK
    CLINICAL RESEARCH, 1984, 32 (04): : A765 - A765
  • [9] PHASE-I TRIAL OF DIPYRIDAMOLE WITH 5-FLUOROURACIL AND FOLINIC ACID
    BUDD, GT
    JAYARAJ, A
    GRABOWSKI, D
    ADELSTEIN, D
    BAUER, L
    BOYETT, J
    BUKOWSKI, R
    MURTHY, S
    WEICK, J
    CANCER RESEARCH, 1990, 50 (22) : 7206 - 7211
  • [10] INHIBITION OF POLYOMA REPLICATION IN VITRO BY 6-METHYLMERCAPTOPURINE RIBOSIDE
    BOWEN, JM
    HUGHES, RG
    DMOCHOWS.L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1969, 10 (MAR): : 9 - &
12345